Abstract:Objective To evaluate the efficacy and safety of the compound felodipine sustained-release tablets in mild to moderate Chinese essential hypertensive patients.Methods This was a randomized,double-blind and double simulation,positive drug parallel control study.One hundred and thirty-five patients from 367 cases with mild to moderate essential hypertension were screened(115 cases in the control group,117 cases of experiment group) randoly into a period of 8 weeks treatment.The experiment group received the compound felodipine sustained-release tablets(enalaprilat maleate 5 mg+felodipine 2.5 mg fixed formulation,1 piece/d) and felodipine simulation agents(2 slices/d),and the control group took the felodipine sustained-release tablets(2.5 mg/plate,2 slices/d) and the compound felodipine simulation agents(1 piece/d).If their blood pressure were still not reached the required standard after 4 weeks treatment,the double dose treatment was initiated.Finally 220 patients completed the test and met the requirements of the trial(111 cases in the control group,109 cases of experiment group).Results The primary efficacy index,change of the diastolic pressure values after therapy in the control group and the experiment group were respectively(-9.3±7.7) and(9.0±8.3) mm Hg after 8 weeks treatment,respectively.Secondary outcome measures included:the sitting systolic blood pressure changed(-7.8±8.9) and(-8.1±9.28)mm Hg respectively,and the sitting diastolic blood pressure changed(-6.0±5.7) and(-5.7±6.4) mm Hg after 4 weeks treatment respectively,the sitting systolic blood pressure changed(-12.3±11.5) and(-11.7±12.9) mm Hg after 8 weeks treatment in the control group and the experiment group,respectively.Control rate of the blood pressure in the control group were 20.9% and 53.9% respectively,and those of the experiment group were 16.2% and 48.7% after 4 and 8 weeks of treatment respectively,and there was no significant difference(P=0.37 and 0.41) between the two groups.The adverse reaction rates of the control group and the experimental group were 5.2% and 10.3% respectively(P=0.22),mainly for the elevation of transaminase and cough.The important adverse event rates of the control group and the experimental group of were 4.3% and 6.8% respectively(P=0.57).Conclusion Compound felodipine sustained release tablets in the treatment of mild to moderate essential hypertension was effective,safe in Chinese hypertensives.

The Efficacy and Safety of the Compound Felodipine Sustained-Release Tablets in Mild to Moderate Essential Hypertension: a Double-Blind Randomized Clinical Trials

Efficacy, Safety and Tolerance of Felodipine Controlled Release Tablets and Felodipine Controlled Release Tablets Associated Combination Therapy in the Treatment of Mild to Moderate Essential Hypertension in China

Efficacy and Safety of the Compound of Candesartan Cilexetial and Hydrochlorothiazide in Patients with Essential Hypertension

Clinical Study of Olmesartan/hydrochlorothiazide Compound Tablet in Mild to Moderate Essential Hypertensive Patients Who Did Not Reach Goal with Olmesartan

Multicenter Clinical Trial on Benidipine in the Treatment of Stable Angina Pectoris

Efficacy Comparison Between 5 Mg Perindopril Arginine Salt and 4 Mg Perindopril Tert-Butylamine Salt for Patients with Mild to Moderate Essential Hypertension

Comparison of efficacy and tolerability of felodipine ER monotherapy and combined felodipine ER and losartan in patients with essential hypertension

Effect of ‘drug Holiday’ on Blood Pressure Control: A Randomized Double-Blind Comparative Trial of Amlodipine Versus Felodipine Extended Release in Chinese Patients with Mild to Moderate Essential Hypertension

Curative Effects on Mild to Moderate Primary Hypertension and Influence on Pulse Wave Velocity of Slow Releasing Felodipine

Studies on the role of the adrenal in anaphylaxis and histamine-shock.

Efficacy and Safety of Olmesartan Medoxomil-Amlodipine Besylate Tablet in Chinese Patients with Essential Hypertension: A Prospective, Single-Arm, Multi-Center, Real-World Study

Comparative Effect of Felodipine and Enalapril in Hypertension

Smooth Blood Pressure Control Obtained with Extended-Release Felodipine in Elderly Patients with Hypertension

The Effectiveness and Safety of L-amlodipine Besylate for Blood Pressure Control in Patients with Mild to Moderate Essential Hypertension

The effect of sexual self-concept on sexual health behavioural intentions: a test of moderating mechanisms in early adolescent girls.

Effect and safety of levoamlodipine maleate tablets on patients with mild-to-moderate hypertension

Efficacy and safety of Qiangli Dingxuan tablet combined with amlodipine besylate for essential hypertension: a randomized, double-blind, placebo-controlled, parallel-group, multicenter trial

Randomized, double-blind, parallel controlled,multicentre clinical trial of fixed combination of nitrendipine and atenolol in the treatment of mild to moderate essential hypertension

Effects of Telmisartan Combined with Nifedipine Controlled Release Tablet on Inflammatory Fac-Tors,vascular Endothelial Function and Left Ventricular Function in Patients with Coronary Heart Disease with Mild to Moderate Hypertension

A clinical trial for evaluating efficacy and safety of amlodipine besylate/atorvastatin calcium in treating hypertension complicated with hyperlipidemia

Effects of Felodipine on Endothelial Function and Atherosclerosis Progression of Large Arteries and Left Ventricular Hypertrophy in Hypertensive Patients